Strategic Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Strategic Financial Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,030	Closed	-$210K	–	123
2023 Q1	$210K	Buy	3,030 +137	+5%	+$9.66K	0.02%	118
2022 Q4	$208K	Hold	2,893	–	–	0.02%	119
2022 Q3	$206K	Hold	2,893	–	–	0.02%	125
2022 Q2	$223K	Sell	2,893 -119	-4%	-$9.06K	0.02%	124
2022 Q1	$220K	Buy	+3,012	New	+$202K	0.02%	132
2021 Q3	–	Sell	-3,297	Closed	-$220K	–	130
2021 Q2	$220K	Buy	3,297 +109	+3%	+$7.11K	0.02%	135
2021 Q1	$201K	Sell	3,188 -164	-5%	-$10.2K	0.02%	134
2020 Q4	$208K	Sell	3,352 -538	-14%	-$33.1K	0.02%	129
2020 Q3	$235K	Sell	3,890 -2,479	-39%	-$149K	0.02%	117
2020 Q2	$374K	Hold	6,369	–	–	0.04%	97
2020 Q1	$355K	Sell	6,369 -485	-7%	-$29.6K	0.05%	99
2019 Q4	$440K	Sell	6,854 -550	-7%	-$31.5K	0.05%	107
2019 Q3	$375K	Sell	7,404 -1,100	-13%	-$51.7K	0.05%	116
2019 Q2	$386K	Sell	8,504 -54	-0.6%	-$2.52K	0.05%	112
2019 Q1	$408K	Hold	8,558	–	–	0.06%	108
2018 Q4	$445K	Buy	+8,558	New	+$460K	0.07%	105

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Strategic Financial Services's BMY Position: Q2 2023 in Review

Strategic Financial Services sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,030 shares — an estimated $210K sold.

Strategic Financial Services first reported a position in BMY in Q4 2018 and held it in 16 quarters. The position peaked at $445K in Q4 2018. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Strategic Financial Services reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Strategic Financial Services sold 3,030 Bristol-Myers Squibb shares in Q2 2023, an estimated $210K.
Strategic Financial Services first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 16 quarters.
Strategic Financial Services's Bristol-Myers Squibb position peaked at $445K in Q4 2018.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Strategic Financial Services's 13F filing for Q2 2023, filed 10 Aug 2023.